Chargement en cours...
Secondary hematological malignancies associated with temozolomide in patients with glioma
BACKGROUND: The alkylating agent temozolomide (TMZ) is widely used for the treatment of gliomas. Although reports of treatment-related myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL) associated with TMZ are accumulating, it remains unclear whether...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3779032/ https://ncbi.nlm.nih.gov/pubmed/23519741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/not036 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|